Published in EMBO J on July 15, 1994
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J (1998) 6.28
Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol (1997) 4.70
Distinct thresholds govern Myc's biological output in vivo. Cancer Cell (2008) 4.16
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A (2001) 3.11
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol (1997) 3.03
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest (1997) 2.93
The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J (1996) 2.71
Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol (1997) 2.71
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J (1996) 2.59
A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A (1998) 2.34
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev (1999) 2.31
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. Nucleic Acids Res (2000) 2.23
Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci U S A (1996) 2.19
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol (1999) 2.17
Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol (2001) 2.15
An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J (1996) 2.09
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest (1995) 2.02
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol (1996) 1.99
Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98
Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J (1995) 1.93
Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol (1998) 1.93
Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J (1995) 1.91
Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci U S A (1997) 1.89
Constitutive expression of the machinery for programmed cell death. J Cell Biol (1996) 1.88
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci U S A (2000) 1.83
Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol (1997) 1.80
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol Cell Biol (2000) 1.71
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci U S A (1999) 1.68
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol (2010) 1.68
Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol (1996) 1.67
Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest (1997) 1.64
Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol (2001) 1.61
Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol (1996) 1.60
OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol (1998) 1.59
The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci U S A (1998) 1.59
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol (2003) 1.59
Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr Biol (2015) 1.58
Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J Cell Biol (1995) 1.55
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.55
c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol (2002) 1.43
Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J (1996) 1.37
A tunable dual-promoter integrator for targeting of cancer cells. Mol Syst Biol (2010) 1.35
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33
Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol (2001) 1.32
CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood (2007) 1.31
MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol (1998) 1.25
Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev (1998) 1.25
Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol (1999) 1.24
Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol (1997) 1.24
Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J (1996) 1.22
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) Br J Cancer (1995) 1.22
Modelling the consequences of interactions between tumour cells. Br J Cancer (1997) 1.20
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol (1995) 1.20
Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J Virol (1998) 1.18
Drosophila grim induces apoptosis in mammalian cells. EMBO J (1998) 1.17
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol (1997) 1.17
Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer (1995) 1.17
The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol (1997) 1.15
Anti-apoptotic activity of low levels of wild-type p53. EMBO J (1996) 1.13
Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol (2004) 1.13
Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J Virol (1995) 1.12
Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol Cell (1995) 1.10
Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage. Am J Pathol (2009) 1.10
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. J Exp Med (1997) 1.08
Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol (2000) 1.08
Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol Cell Biol (1995) 1.07
Myc: the beauty and the beast. Genes Cancer (2010) 1.07
Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. J Virol (1996) 1.06
Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia (1999) 1.06
Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J (1997) 1.05
More than one way to go. Proc Natl Acad Sci U S A (2001) 1.04
Viral-mediated noisy gene expression reveals biphasic E2f1 response to MYC. Mol Cell (2011) 1.03
Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells. J Virol (1996) 1.03
Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers. Chin J Cancer (2012) 1.01
Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol (1998) 1.01
Drosophila damaged DNA-binding protein 1 is an essential factor for development. Genetics (2004) 1.01
Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Hepatology (2010) 1.00
A mouse model of uterine leiomyosarcoma. Am J Pathol (2004) 0.99
Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig Dis Sci (2003) 0.98
Apoptosis and inflammation. Mediators Inflamm (1995) 0.96
Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses. Virchows Arch (2011) 0.96
Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells. Mol Cell Proteomics (2009) 0.95
Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein. Mol Cell Biol (2000) 0.94
Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis. Proc Natl Acad Sci U S A (1997) 0.92
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer (2011) 0.92
The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br J Cancer (1995) 0.92
Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol Cell Biol (1995) 0.91
Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor. Mol Cell Biol (2010) 0.89
The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts. Mol Biol Cell (1998) 0.89
Modulation of the chaperone heat shock cognate 70 by embryonic (pro)insulin correlates with prevention of apoptosis. Proc Natl Acad Sci U S A (1998) 0.89
Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis. Br J Cancer (1997) 0.87
Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cells. Retrovirology (2004) 0.87
Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation. J Biol Chem (2014) 0.86
Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity. World J Gastroenterol (2004) 0.85
Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart (2001) 0.84
Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis. Clin Exp Immunol (2008) 0.84
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
G1 events and regulation of cell proliferation. Science (1989) 9.73
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
Early signals in the mitogenic response. Science (1986) 5.89
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell (1991) 5.76
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene (1991) 5.32
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A (1993) 5.13
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (1987) 4.85
Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (1992) 4.75
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Programmed cell death and the control of cell survival: lessons from the nervous system. Science (1993) 4.63
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45
An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol (1990) 4.24
Apoptosis. Immunol Today (1993) 4.23
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol (1992) 4.17
Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10
Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J (1990) 3.59
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
Max: functional domains and interaction with c-Myc. Genes Dev (1992) 2.88
Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc Natl Acad Sci U S A (1985) 2.65
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol (1993) 2.56
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol (1988) 2.20
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res (1992) 2.15
Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem (1986) 2.00
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol Cell Biol (1988) 1.76
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med (1992) 1.65
C-myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene (1991) 1.44
Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol (1990) 1.38
A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res (1987) 1.33
Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem (1989) 1.14
Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol (1990) 1.14
Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein. Oncogene (1990) 1.08
Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: counteractive effect of addition of purified growth factors. J Cell Sci (1985) 1.05
The double life of the IGF-1 receptor. Receptor (1992) 0.91
Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells. In Vitro Cell Dev Biol (1989) 0.87
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol (2000) 9.87
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature (2006) 4.57
Transmission from intramural inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 4.22
Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10
Induction of apoptosis by the Bcl-2 homologue Bak. Nature (1995) 3.56
Interaction between the origin recognition complex and the replication licensing system in Xenopus. Cell (1996) 3.45
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A (1984) 3.31
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J (1986) 3.07
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol (1997) 3.03
Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by chicken c-myb gene. Cell (1984) 2.98
Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell (1985) 2.95
Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol (1999) 2.65
Rebound excitation of the smooth muscle cells of the guinea-pig taenia coli after stimulation of intramural inhibitory nerves. J Physiol (1966) 2.64
The formation of synapses in striated muscle during development. J Physiol (1974) 2.58
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science (1997) 2.52
Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res (2000) 2.50
Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol Cell Biol (1984) 2.50
Transmission from perivascular inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 2.48
The Drosophila caspase DRONC is regulated by DIAP1. EMBO J (2000) 2.46
A study of the innervation of the taenia coli. J Cell Biol (1967) 2.15
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest (1995) 2.02
A monoclonal anti-HLA antibody recognizes a mouse tumor-associated antigen. Eur J Immunol (1983) 1.97
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci U S A (2000) 1.97
Oncogenes and cell death. Curr Opin Genet Dev (1994) 1.97
The formation of synapses in reinnervated mammalian striated muscle. J Physiol (1973) 1.79
An analysis of the transmission of excitation from autonomic nerves to smooth muscle. J Physiol (1966) 1.77
The formation of synapses in reinnervated and cross-reinnervated adult avian muscle. J Physiol (1973) 1.77
A statistical analysis of the release of acetylcholine at newly formed synapses in striated muscle. J Physiol (1974) 1.75
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
c-myc protein expression in untransformed fibroblasts. Oncogene (1991) 1.72
Transmission from intramural excitatory nerves to the smooth muscle cells of the guinea-pig taenia coli. J Physiol (1966) 1.66
Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE. EMBO J (1997) 1.61
An electrophysiological analysis of the effects of amine-uptake blockers and alpha-adrenoceptor blockers on adrenergic neuromuscular transmission. Br J Pharmacol (1975) 1.54
Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res (2000) 1.53
Model of the membrane of smooth muscle cells of the guinea-pig taenia coli muscle during transmission from inhibitory and excitatory nerves. Nature (1966) 1.52
Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life (2000) 1.50
An electrophysiological analysis of the storage of acetylcholine in preganglionic nerve terminals. J Physiol (1972) 1.49
The effect of calcium ions on the binomial statistic parameters that control acetylcholine release at preganglionic nerve terminals. J Physiol (1976) 1.49
Transcription factors 2: helix-loop-helix. Protein Profile (1995) 1.48
Bronchiolitis obliterans organizing pneumonia with migratory pulmonary infiltrates. AJR Am J Roentgenol (1992) 1.47
The formation of synapses in amphibian striated muscle during development. J Physiol (1975) 1.47
Buprenorphine kinetics. Clin Pharmacol Ther (1980) 1.47
drICE is an essential caspase required for apoptotic activity in Drosophila cells. EMBO J (1997) 1.46
The effect of cations on the electrical properties of the smooth muscle cells of the guinea-pig vas deferens. J Physiol (1967) 1.39
The effect of calcium ions on the secretion of quanta evoked by an impulse at nerve terminal release sites. J Gen Physiol (1979) 1.39
Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol (1990) 1.38
Xenopus myc proto-oncogene during development: expression as a stable maternal mRNA uncoupled from cell division. EMBO J (1986) 1.35
The formation of synapses in mammalian striated muscle reinnervated with autonomic preganglionic nerves. J Physiol (1973) 1.34
The effect of calcium ions on the binomial statistic parameters which control acetylcholine release at synapses in striated muscle. J Physiol (1975) 1.33
A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res (1987) 1.33
The effect of intracellular current pulses in smooth muscle cells of the guinea pig vas deferens at rest and during transmission. J Gen Physiol (1967) 1.33
An electrophysiological analysis of the effect of Ca ions on neuromuscular transmission in the mouse vas deferens. Br J Pharmacol (1975) 1.33
The formation and regression of synapses during the re-innervation of axolotl striated muscles. J Physiol (1977) 1.32
The formation of neuromuscular synapses. Cold Spring Harb Symp Quant Biol (1976) 1.30
CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited by direct physical association with CED-9. Curr Biol (1997) 1.30
An electrophysiological analysis of the uptake of noradrenaline at sympathetic nerve terminals. J Physiol (1973) 1.30
An electrophysiological analysis of the synthesis of acetylcholine in preganglionic nerve terminals. J Physiol (1972) 1.30
Cell death in atherosclerotic plaques. Curr Opin Lipidol (1996) 1.29
Application of the sucrose-gap method to determine the ionic basis of the membrane potential of smooth muscle. J Physiol (1966) 1.27
Death by any other name. Am J Pathol (1995) 1.26
Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol (2001) 1.26
Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem (2000) 1.25
Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol (1997) 1.24
Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci (1994) 1.23
Comparative study on the distribution patterns of P2X(1)-P2X(6) receptor immunoreactivity in the brainstem of the rat and the common marmoset (Callithrix jacchus): association with catecholamine cell groups. J Comp Neurol (2000) 1.23
The formation of synapses in reinnervated and cross-reinnervated striated muscle during development. J Physiol (1974) 1.22
A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material. J Immunol Methods (1985) 1.21
An electrophysiological analysis of the storage and release of noradrenaline at sympathetic nerve terminals. J Physiol (1973) 1.21
The loss of ganglion cells in the developing retina of the rat. Brain Res (1982) 1.20
The probability of quantal secretion along visualized terminal branches at amphibian (Bufo marinus) neuromuscular synapses. J Physiol (1986) 1.19
Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition. J Physiol (1997) 1.19
Traps to catch unwary oncogenes. Trends Genet (1998) 1.19
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice. Diabetologia (2011) 1.19
Probabilistic secretion of quanta from visualized sympathetic nerve varicosities in mouse vas deferens. J Physiol (1992) 1.18
The radioimmunoassay of buprenorphine. Eur J Clin Pharmacol (1980) 1.17
Methods for detecting and quantifying apoptosis. Curr Top Dev Biol (1998) 1.16
Omomyc expression in skin prevents Myc-induced papillomatosis. Cell Death Differ (2004) 1.16
Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes. J Virol (1995) 1.16
Does footprint depth correlate with foot motion and pressure? J R Soc Interface (2013) 1.15
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest (1994) 1.14
Transcription factors 2: helix-loop-helix. Protein Profile (1994) 1.13
Metabotropic receptor activation, desensitization and sequestration-I: modelling calcium and inositol 1,4,5-trisphosphate dynamics following receptor activation. J Theor Biol (2003) 1.12
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene (1989) 1.11
An electrophysiological analysis of the effects of reserpine on adrenergic neuromuscular transmission. Br J Pharmacol (1975) 1.09
Development of neuromuscular synapses. Physiol Rev (1983) 1.08
Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein. Oncogene (1990) 1.08
An analysis of the surface fixed-charge theory of the squid giant axon membrane. Biophys J (1967) 1.07
The formation of synapses in regenerating mammalian striated muscle. J Physiol (1974) 1.06
An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens. Br J Pharmacol (1980) 1.06
Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene. Mol Cell Biol (1984) 1.06
Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J (1997) 1.05
Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Br J Cancer (1987) 1.05